The short version of mass spectrometry fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-02-10. Anything still debated is marked as such rather than presented as settled.
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
Most published work on BPC-157 comes from animal experiments rather than controlled human trials. Rodent models have examined its effects on gastrointestinal lesions, tendon and ligament injury, and blood vessel formation. These studies are often small and originate from a limited number of research groups, which affects how broadly the findings can be generalized. No large randomized human trial has been reported in the peer-reviewed literature. Discussion of the compound therefore rests largely on preclinical data, and questions about its effects in people remain open rather than settled.
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic pentadecapeptide | Composed of fifteen amino acid residues |
| Amino acid sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | Single-letter form GEPPPGKPADDAGLV |
| Original source | Fragment of a protein in human gastric juice | First characterized in the 1990s |
| Number in name | 157 | Refers to the fragment's position in the source protein |
| Human trial evidence | Limited | Preclinical rodent data predominate |
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Quality assessment rests on two separate questions: whether the chain is the intended one, and how much of the sample is that chain. Reverse-phase high-performance liquid chromatography with ultraviolet detection is the standard purity measurement, while mass spectrometry confirms identity through the observed molecular mass. Amino acid analysis and sequence verification provide further checks. A reported purity percentage describes the proportion of the sample represented by the main peak, not the amount of peptide by mass, since counter-ions and water make up part of any lyophilized lot.
In its usual supplied form, the peptide is a white to off-white lyophilized powder that dissolves readily in water and in aqueous buffers. Powder keeps far longer than solution, so material is normally shipped and stored dry, then dissolved only when needed. Once in solution, the chain is subject to hydrolysis and the liquid supports microbial growth, and practical guidance generally treats the dissolved form as short-lived. Containers should stay sealed and desiccated, because the powder takes up moisture from air.
Identity and purity are checked with standard peptide techniques. Reversed-phase high-performance liquid chromatography separates the main peak from closely related impurities and yields a percentage purity. Mass spectrometry confirms that the measured mass matches the theoretical value. Amino acid analysis offers an independent check on overall composition. These analytical methods characterize the material itself and reveal nothing about how it behaves in a living system.
In its common research form the peptide is supplied as a lyophilized powder. It dissolves readily in water and in typical aqueous buffers, which simplifies preparation of working solutions. Laboratories usually prepare small aliquots instead of one large volume. The dry material appears as a white to off-white solid with no distinctive odor. Bulk quantities are typically shipped in sealed vials.
Lyophilized material is generally kept cold, commonly at minus twenty degrees Celsius, and shielded from moisture and light. Solutions are less stable than the dry powder, so repeated freeze-thaw cycles are avoided by splitting the material into single-use portions. Published stability data for this particular peptide are limited, which means suggested hold times should be read as provisional. Long-term refrigeration of reconstituted solutions is not well supported by available evidence.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
== Selected publications == Moloney, P. J. (1926). "The preparation and testing of diphtheria toxoid (Anatoxine-Ramon)". American Journal of Public Health. 16 (12): 1208–1210. doi:10.2105/AJPH.16.12.1208. PMC 1321494. PMID 18012024. Moloney, P. J.; Fraser, C. J. (1927). "Immunization with diphtheria toxoid (anatoxine Ramon)". American Journal of Public Health. 17 (10): 1027–1030. doi:10.2105/AJPH.17.10.1027. PMC 1321911. PMID 18012293. Taylor, E. M.; Moloney, P. J. (1939). "A New Schick-Toxin". The Journal of Immunology. 37 (3): 223–232. doi:10.4049/jimmunol.37.3.223. S2CID 86572393. Fitzgerald, J. G.; Defries, R. D.; Fraser, D. T.; Moloney, P. J.; McKinnon, N. E. (1932). "Experiences with Diphtheria Toxoid in Canada". American Journal of Public Health and the Nation's Health. 22 (1): 25–28. doi:10.2105/ajph.22.1.25. PMC 1556712. PMID 18013424. Moloney, P. J.; Hennessy, J. N. (1942). "Purification of tetanus toxoid". The Biochemical Journal. 36 (7–9): 544–547. doi:10.1042/bj0360544. PMC 1266838. PMID 16747558. Moloney, P. J.; Hennessy, Joan N. (1944). "Titration of Tetanal Toxins and Toxoids by Flocculation". The Journal of Immunology. 48 (6): 345–354. doi:10.4049/jimmunol.48.6.345. S2CID 88201977. Moloney, P. J.; Coval, M. (1955). "Antigenicity of insulin: Diabetes induced by specific antibodies". The Biochemical Journal. 59 (2): 179–185. doi:10.1042/bj0590179. PMC 1216116. PMID 14351177. Moloney, P. J.; Goldsmith, L. (1957). "On the Antigenicity of Insulin". Canadian Journal of Biochemistry and Physiology. 35 (1): 79–92. doi:10.1139/y57-011. PMID 13396665.
=== Protein degradation === Protein degradation may take place intracellularly or extracellularly. In digestion of food, digestive enzymes may be released into the environment for extracellular digestion whereby proteolytic cleavage breaks proteins into smaller peptides and amino acids so that they may be absorbed and used. In animals the food may be processed extracellularly in specialized organs or guts, but in many bacteria the food may be internalized via phagocytosis. Microbial degradation of protein in the environment can be regulated by nutrient availability. For example, limitation for major elements in proteins (carbon, nitrogen, and sulfur) induces proteolytic activity in the fungus Neurospora crassa as well as in of soil organism communities. Proteins in cells are broken into amino acids. This intracellular degradation of protein serves multiple functions: It removes damaged and abnormal proteins and prevents their accumulation. It also serves to regulate cellular processes by removing enzymes and regulatory proteins that are no longer needed. The amino acids may then be reused for protein synthesis.
== Bibliography == Silva, Robert J. (2006). "Fermium, Mendelevium, Nobelium, and Lawrencium" (PDF). In Morss, Lester R.; Edelstein, Norman M.; Fuger, Jean (eds.). The Chemistry of the Actinide and Transactinide Elements. Vol. 3 (3rd ed.). Dordrecht: Springer. pp. 1621–1651. doi:10.1007/1-4020-3598-5_13. ISBN 978-1-4020-3555-5. Archived from the original (PDF) on 2010-07-17.
== # == 2-amino-4-deoxychorismate dehydrogenase - 2-dehydropantolactone reductase (B-specific) - 2-methylacyl-CoA dehydrogenase - 2-nitropropane dioxygenase - 2-oxobutyrate synthase - (2,3-dihydroxybenzoyl)adenylate synthase - 2,4-Dihydroxy-1,4-benzoxazin-3-one-glucoside dioxygenase - 2010107G12Rik - 27-hydroxycholesterol 7alpha-monooxygenase - 3' end - 3' flanking region - 3-hydroxy-2-methylpyridinecarboxylate dioxygenase - 3-Ketosteroid 9alpha-monooxygenase - 3-oxoacyl-(acyl-carrier-protein) reductase (NADH) - (3,5-dihydroxyphenyl)acetyl-CoA 1,2-dioxygenase - 3(or 17)a-hydroxysteroid dehydrogenase - 3110001I22Rik - 3alpha-hydroxyglycyrrhetinate dehydrogenase - 4932414N04Rik - 3alpha-hydroxysteroid dehydrogenase (A-specific) - 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase - 3alpha,7alpha,12alpha-trihydroxycholestan-26-al 26-oxidoreductase - 4-Cresol dehydrogenase (hydroxylating) - 4-Hydroxycyclohexanecarboxylate dehydrogenase - 4-hydroxyphenylacetaldehyde oxime monooxygenase - 4-hydroxyphenylpyruvate oxidase - 4-Nitrophenol 4-monooxygenase - 4933425L06Rik - 5' end - 5' flanking region - 5-pyridoxate dioxygenase - 6-endo-hydroxycineole dehydrogenase - 7-deoxyloganin 7-hydroxylase - 7beta-hydroxysteroid dehydrogenase (NADP+) - 8-oxocoformycin reductase - 12beta-hydroxysteroid dehydrogenase - 25-hydroxycholesterol 7α-hydroxylase -
Sources: en.wikipedia.org
==== Enzymes used ==== A commonly used protease mixture is "Flavourzyme", extracted from Aspergillus oryzae, the mold used for soy sauce production. This mixture contains both endo- and exo-peptidases. The endopeptidase Alcalase may also be used, but without an exopeptidase it tends to generate a bitter flavor. As a result, it should be used with a companion exopeptidase. A commercial exopeptidase produced for this purpose is "Protana Prime", a mixture with both leucine aminopeptidase and carboxypeptidase D activity. Beyond proteolysis, the amount of umami taste can also be increased by adding a glutaminase, which converts glutamine to glutamate. Commercial options include "Protana Boost" and others.
=== Hydrogen nuclear magnetic resonance === Hydrogen nuclear magnetic resonance (2HNMR) is a technique that uses an external magnetic field and deuterium to replace the ordinary form of hydrogen. The ordinary form of hydrogen refers to the elemental form of hydrogen with a molecular weight of approximately 1 g/mol. It contains only one proton and has no neutrons. Deuterium is the isotope form of hydrogen which has a heavier mass compared to ordinary hydrogen. It contains one proton and neutron and has a molecular weight of approximately 2 g/mol. This technique can be used to investigate motions of acyl chains in lipids. It measures carbon and deuterium interactions and the mobility of these interactions within various regions of the lipid and also determines order parameters. The process involves using quadrupole signaling properties for examining lamellar versus non–lamellar phases as well. An external magnetic field monitors the alignment of paramagnetic compounds and uses changes in the positive or negative magnetic spin values to detect these changes.
== Arrests == On 13 July 2011, operations chief and one of the founders of the organization, Martin Arzola Ortega, was arrested. On 7 August 2012, it was announced that Ortega's successor, Eliot Alberto Radillo Peza, was captured in Zapopan, Jalisco. At the time of Peza's arrest, it was announced that twelve suspected members of the Jalisco Nueva Generacion cartel, including leaders Martin Arzola and Abundio Mendoza Gaytan, had been arrested since July 2011 on extortion, kidnapping and drug charges. On 9 March 2012, another founder of the organization, Érick Valencia Salazar, alias El 85, was captured by the Mexican Army along with another high-ranking lieutenant in Zapopan, Jalisco. Their apprehensions prompted over a dozen blockades throughout the city. 26 public transportation buses were burned with gasoline and then used to block the city streets. More than 30 assault rifles, grenades, cartridges, and ammunition magazines were confiscated. Felipe Calderón, the president of Mexico, congratulated the Mexican army for the capture of Érick Valencia Salazar. The Matazetas (CJNG) later apologized for the blockades by putting up several banners throughout the Guadalajara metropolitan area. They wrote that the blockades were "only a reaction for messing with their CJNG companion", who reportedly dedicated his work to "maintain tranquility in the state of Jalisco." On 18 March 2012, José Guadalupe Serna Padilla, another ranking lieutenant in the cartel, was captured along with another cartel member as well.
compared to Urey model using reduced partition function ratios. Piasecki et al. performed first-principles calculations of the equilibrium distributions of all substituted isotopologues of methane. The overall conclusion of theoretical studies is
== Chain standards == Standards organizations (such as ANSI and ISO) maintain standards for design, dimensions, and interchangeability of transmission chains. For example, the following table shows data from ANSI standard B29.1-2011 (precision power transmission roller chains, attachments, and sprockets) developed by the American Society of Mechanical Engineers (ASME). See the references for additional information.
Sources: en.wikipedia.org
When yeast cells die, they sink to the bottom of the fermentation vessel where they combine with insoluble tartrates, grape seeds, skin and pulp fragments to form the lees. During fermentation, the first significant racking which removes the bulk of dead yeast cells is often referred to as the gross lees as opposed to the less coarse fine lees that come as the wine continues to settle and age. During the time that the wine spends in contact with the lees, a number of changes can impact the wine due to both the autolysis (or self-metabolize) of the dead yeast cells as well as the reductive conditions that can develop if the lees are not aerated or stirred (a process that the French call bâtonnage). The length of time that a wine spends on its lees (called sur lie) will depend on the winemaking style and type of wine. The process of leaving the wine to spend some contact with the lees has a long history in winemaking, being known to the Ancient Romans and described by Cato the Elder in the 2nd century BC. Today the practice is widely associated with any red wines that are barrel fermented, Muscadet, sparkling wine Champagne as well as Chardonnay produced in many wine regions across the globe. Typically when wines are left in contact with their lees, they are regularly stirred in order to release the mannoproteins, polysaccharides and other compounds that were present in the yeast cell walls and membranes.
=== No risk for hypervitaminosis A === At the enterocyte cell wall, β-carotene is taken up by the membrane transporter protein scavenger receptor class B, type 1 (SCARB1). Absorbed β-carotene is then either incorporated as such into chylomicrons or first converted to retinal and then retinol, bound to retinol binding protein 2, before being incorporated into chylomicrons. The conversion process consists of one molecule of β-carotene cleaved by the enzyme beta-carotene 15,15'-dioxygenase, which is encoded by the BCO1 gene, into two molecules of retinal. When plasma retinol is in the normal range the gene expression for SCARB1 and BCO1 are suppressed, creating a feedback loop that suppresses absorption and conversion. Because of these two mechanisms, high intake will not lead to hypervitaminosis A.
In June 2012, Riff Raff released the .Summer of Surf mixtape. He signed with Diplo's label Mad Decent in June 2012. The same year he released the album, The Golden Alien, independently in July which feature tracks produced by MikeChekMusic, "Freeze Dried", "Obtuse Angle". It was followed by the release of the mixtape, Birth of an Icon, in August, which was listed by Stereogum as their "Mixtape of the Week".
Duration of diabetes Age/life expectancy Comorbidity Known cardiovascular disease or advanced microvascular disease Hypoglycemia awareness In older people, clinical practice guidelines by the American Geriatrics Society recommend, in frail people who have a life expectancy of less than 5 years, a target a Hb A1c of 8% is appropriate as the risk of very low blood sugar outweighs the long term benefits of a lower A1c. When comparing the effects of tight versus conventional (more relaxed) glycemic control in type 2 diabetics, studies failed to demonstrate a difference in all-cause cardiovascular death, non-fatal stroke, or limb amputation, but decreased the risk of nonfatal myocardial infarction (heart attack) by 15%. Additionally, tight glucose control decreased the risk of progression of kidney, nerve, and eye complications, but increased the risk of severe hypoglycemia.
To provide a deeper scientific foundation for MD students, Einstein hosts the five-year Clinical Research Training Program (CRTP). The CRTP confers a Master of Science and requires an additional year of courses on clinical research methods. Students may also graduate with distinction in research for their medical degree. With Yeshiva's Benjamin N. Cardozo School of Law, Einstein offers both a certificate and Master of Science in Bioethics. The program covers clinical bioethics consultation, healthcare ethics policy, and human subject research. Einstein also offers MD students a joint Master of Public Health degree with the City University of New York (CUNY). This Einstein-CUNY MD-MPH program lasts five years.
Sources: en.wikipedia.org
It is a chain of fifteen amino acids, referred to as a pentadecapeptide. The sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It corresponds to a fragment of a protein found in human gastric juice.
It is neither a naturally circulating hormone nor an approved medicine in most countries. It is a synthetic peptide fragment used chiefly as a laboratory research material. Its regulatory status varies by jurisdiction, and it is not authorized as a therapeutic product in the United States or the European Union.
Published human evidence is very limited. Most findings come from rodent studies conducted by a small number of groups. As a result, statements about its effects in humans are generally described as uncertain rather than established.
It is a synthetic peptide. Its design was inspired by a fragment of a protein found in human gastric juice, but the fifteen-amino-acid molecule itself is made in a laboratory and is not a normal component of food or of human tissue in appreciable amounts.